JP2016532722A5 - - Google Patents

Download PDF

Info

Publication number
JP2016532722A5
JP2016532722A5 JP2016546886A JP2016546886A JP2016532722A5 JP 2016532722 A5 JP2016532722 A5 JP 2016532722A5 JP 2016546886 A JP2016546886 A JP 2016546886A JP 2016546886 A JP2016546886 A JP 2016546886A JP 2016532722 A5 JP2016532722 A5 JP 2016532722A5
Authority
JP
Japan
Prior art keywords
composition
amount
less
storage
month
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016546886A
Other languages
English (en)
Japanese (ja)
Other versions
JP6516759B2 (ja
JP2016532722A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/058911 external-priority patent/WO2015051183A1/en
Publication of JP2016532722A publication Critical patent/JP2016532722A/ja
Publication of JP2016532722A5 publication Critical patent/JP2016532722A5/ja
Application granted granted Critical
Publication of JP6516759B2 publication Critical patent/JP6516759B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016546886A 2013-10-03 2014-10-02 安定化エフィナコナゾール組成物 Active JP6516759B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361886569P 2013-10-03 2013-10-03
US61/886,569 2013-10-03
US201461922867P 2014-01-01 2014-01-01
US61/922,867 2014-01-01
PCT/US2014/058911 WO2015051183A1 (en) 2013-10-03 2014-10-02 Stabilized efinaconazole compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019041262A Division JP6774518B2 (ja) 2013-10-03 2019-03-07 安定化エフィナコナゾール組成物

Publications (3)

Publication Number Publication Date
JP2016532722A JP2016532722A (ja) 2016-10-20
JP2016532722A5 true JP2016532722A5 (enExample) 2017-11-09
JP6516759B2 JP6516759B2 (ja) 2019-05-22

Family

ID=52777446

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016546886A Active JP6516759B2 (ja) 2013-10-03 2014-10-02 安定化エフィナコナゾール組成物
JP2019041262A Active JP6774518B2 (ja) 2013-10-03 2019-03-07 安定化エフィナコナゾール組成物
JP2020118180A Pending JP2020169207A (ja) 2013-10-03 2020-07-09 安定化エフィナコナゾール組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019041262A Active JP6774518B2 (ja) 2013-10-03 2019-03-07 安定化エフィナコナゾール組成物
JP2020118180A Pending JP2020169207A (ja) 2013-10-03 2020-07-09 安定化エフィナコナゾール組成物

Country Status (13)

Country Link
US (4) US9662394B2 (enExample)
EP (1) EP3052487B1 (enExample)
JP (3) JP6516759B2 (enExample)
KR (1) KR102320051B1 (enExample)
CN (2) CN110433291B (enExample)
AU (1) AU2014329421B2 (enExample)
CA (1) CA2924748C (enExample)
IL (1) IL244850B (enExample)
MX (1) MX363386B (enExample)
MY (1) MY179756A (enExample)
PH (1) PH12016500586B1 (enExample)
SG (1) SG11201602596UA (enExample)
WO (1) WO2015051183A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
MY179756A (en) 2013-10-03 2020-11-12 Dow Pharmaceutical Sciences Stabilized efinaconazole formulations
EP3071295A4 (en) 2013-11-22 2017-05-31 Dow Pharmaceutical Sciences, Inc. Anti-infective methods, compositions, and devices
CN106918672B (zh) * 2015-12-28 2021-02-09 中美华世通生物医药科技（武汉）有限公司 利用hplc测定艾氟康唑原料药及其制剂中有关物质的方法
CN110087652A (zh) * 2016-12-16 2019-08-02 株式会社钟化 甲癣治疗剂
WO2019077163A2 (en) * 2017-10-20 2019-04-25 Galenicum Health S.L. PHARMACEUTICAL DEVICE
JP7430070B2 (ja) * 2019-02-08 2024-02-09 沢井製薬株式会社 エフィナコナゾール含有爪外用液
KR102352960B1 (ko) * 2019-06-07 2022-01-19 주식회사 바이오빌리프 에피나코나졸을 함유하는 용액 형태의 국소 투여용 약학 조성물
KR102060546B1 (ko) * 2019-06-07 2019-12-30 주식회사 바이오빌리프 에피나코나졸을 함유하는 용액 형태의 국소 투여용 약학 조성물
WO2021054535A2 (ko) * 2019-09-17 2021-03-25 주식회사 바이오빌리프 킬레이트화제, 항산화제, 및 산의 조합을 포함하는 안정화된 에피나코나졸-함유 약학 조성물
KR20210032665A (ko) * 2019-09-17 2021-03-25 주식회사 바이오빌리프 킬레이트화제 및 항산화제의 조합을 포함하는 안정화된 에피나코나졸-함유 약학 조성물
KR20210032672A (ko) * 2019-09-17 2021-03-25 주식회사 바이오빌리프 에피나코나졸을 함유하는 안정화된 약학 조성물
KR20210032662A (ko) * 2019-09-17 2021-03-25 주식회사 바이오빌리프 킬레이트화제를 포함하는 안정화된 에피나코나졸-함유 약학 조성물
WO2021054533A2 (ko) * 2019-09-17 2021-03-25 주식회사 바이오빌리프 산으로서 소르빈산을 포함하는 안정화된 에피나코나졸-함유 약학 조성물
WO2021054531A2 (ko) * 2019-09-17 2021-03-25 주식회사 바이오빌리프 항산화제를 포함하는 안정화된 에피나코나졸-함유 약학 조성물
KR102266145B1 (ko) 2019-09-26 2021-06-17 대봉엘에스 주식회사 비정질 에피나코나졸 고체 분산체
JP2021054781A (ja) 2019-09-26 2021-04-08 デボン エルエス，リミテッド 共結晶形エフィナコナゾール、及びその製造方法
WO2021132348A1 (ja) * 2019-12-24 2021-07-01 科研製薬株式会社 エフィナコナゾールを含有する医薬
KR102394599B1 (ko) * 2020-03-19 2022-05-06 동아에스티 주식회사 에피나코나졸을 함유하는 국소 투여용 약학 조성물
US20230226033A1 (en) * 2020-06-03 2023-07-20 The Materia Company Limited Stable formulation of efinaconazole
JP7664026B2 (ja) * 2020-08-06 2025-04-17 沢井製薬株式会社 エフィナコナゾール含有爪外用液
JP2022547755A (ja) * 2020-08-14 2022-11-16 ビーエルアンドエイチ カンパニー，リミテッド 白癬を防止又は処置するための医薬組成物
KR102729906B1 (ko) 2020-10-30 2024-11-14 주식회사 대웅제약 항진균제를 포함하는 안정화된 조성물
KR102301743B1 (ko) * 2020-12-29 2021-09-13 대봉엘에스 주식회사 에피나코나졸 경구용 조성물
US20240108613A1 (en) * 2021-02-05 2024-04-04 Acp Laboratories Llc Topical composition for treating fungi forming on a user's body
WO2022235048A1 (ko) * 2021-05-04 2022-11-10 주식회사 제뉴원사이언스 에피나코나졸을 함유하는 액상 형태의 약학적 조성물
KR102863832B1 (ko) * 2021-05-04 2025-09-25 주식회사 제뉴원사이언스 에피나코나졸을 함유하는 액상 형태의 약학적 조성물
KR20230158920A (ko) 2022-05-12 2023-11-21 주식회사한국파마 에피나코나졸을 함유하는 안정화된 국소투여용 약학 조성물
KR102842759B1 (ko) 2022-05-20 2025-08-06 주식회사한국파마 항진균제로서 에피나코나졸을 함유하는 약학 조성물
KR102597564B1 (ko) * 2023-03-03 2023-11-03 장병모 조갑 및 피부 백선의 예방 또는 치료용 약학적 조성물
WO2026039635A1 (en) * 2024-08-14 2026-02-19 Foundling Pharma, Llc Improved compositions and methods for topical treatment

Family Cites Families (117)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE41306C (de) A. STORIE VAN DEN ABEELE in Brügge, Belgien Tabak-Trockner
US3655290A (en) 1970-10-02 1972-04-11 Griffith & Associates Inc Applicator instrument
US4052513A (en) 1974-12-13 1977-10-04 Plough, Inc. Stable topical anesthetic compositions
DE3106635A1 (de) 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften
US4384589A (en) 1981-07-27 1983-05-24 American Cyanamid Company Novel liquid delivery system for toiletries
US4912124A (en) 1984-02-23 1990-03-27 Ortho Pharmaceutical Corporation Antifungal dermatological solution
JPS6234955A (ja) 1985-08-01 1987-02-14 ダウ　コ−ニング　コ−ポレ−ション 透明シリコ−ン組成物
DE3687458T2 (de) 1985-11-04 1993-07-29 Owen Galderma Lab Inc Filmbildende arzneimitteltraeger zur verabreichung von arzneimitteln an naegeln
DE3544983A1 (de) 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
US5208257A (en) * 1986-04-21 1993-05-04 Kabara Jon J Topical antimicrobial pharmaceutical compositions and methods
JPS63188609A (ja) 1987-01-30 1988-08-04 Sansho Seiyaku Kk 着色を防止した外用剤
DE3720147A1 (de) 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
CA2008775C (en) 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
FR2673537B1 (fr) 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
US5449715A (en) * 1991-09-17 1995-09-12 Isp Investments Inc. Colorless, non-toxic, stabilized aqueous solution of a C1-C5 alkyl vinyl ether and maleic acid copolymers
CA2129828A1 (en) 1992-02-12 1993-08-19 Giovanni Lucchetti Liposomal itraconazole formulations
DE4212105A1 (de) 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nagellack zur Behandlung von Onychomykosen
GB9308103D0 (en) 1993-04-20 1993-06-02 Unilever Plc Cosmetic composition
CN1046278C (zh) 1993-05-10 1999-11-10 科研制药株式会社 吡咯胺衍生物
US5391367A (en) 1993-07-28 1995-02-21 Pfizer Inc. Antifungal nail solution
US5916545A (en) 1993-07-28 1999-06-29 Pfizer Inc. Antifungal nail solution
US5461068A (en) 1993-09-29 1995-10-24 Corwood Laboratories, Inc. Imidazole derivative tincture and method of manufacture
EP0721348B1 (en) 1993-09-29 1999-09-01 Alza Corporation Monoglyceride/lactate ester permeation enhancer
JP3608209B2 (ja) 1993-10-27 2005-01-05 大正製薬株式会社 クロタミトン配合外用剤
FR2711898B1 (fr) 1993-11-05 1995-12-29 Oreal Pinceau pour appliquer du vernis à ongles, ou un produit analogue.
US6040266A (en) 1994-02-22 2000-03-21 Ultramet Foam catalyst support for exhaust purification
FR2717057B1 (fr) 1994-03-14 1996-04-12 Oreal Pinceau de vernis à ongles et ensemble d'application de vernis à ongles muni d'un tel pinceau.
US5487776A (en) 1994-03-17 1996-01-30 Nimni; Marcel Anti-fungal nail lacquer and method therefor
US6538039B2 (en) 1994-04-29 2003-03-25 Laboratoire L. Lafon Pharmaceutical dosage form for transdermal administration
WO1996007396A2 (en) 1994-09-07 1996-03-14 Johnson & Johnson Consumer Products, Inc. Retinoid compositions
US5696164A (en) 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
WO1996030011A1 (en) 1995-03-30 1996-10-03 Bioplex, L.C. Topical antimycotic compositions
US5549930A (en) 1995-05-25 1996-08-27 Reysis; Moisei Dryer and top coat for nail polish
US7094422B2 (en) 1996-02-19 2006-08-22 Acrux Dds Pty Ltd. Topical delivery of antifungal agents
US5696105A (en) 1996-03-14 1997-12-09 Hackler; Walter A. Antifungal nail composition
US5874069A (en) 1997-01-24 1999-02-23 Colgate-Palmolive Company Cosmetic composition containing silicon-modified amides as thickening agents and method of forming same
JP4227677B2 (ja) 1996-12-10 2009-02-18 杏林製薬株式会社 被膜形成性抗真菌剤組成物
EP0971746A1 (en) 1997-03-31 2000-01-19 Johnson & Johnson Consumer Companies, Inc. Solvent system for enhanced penetration of pharmaceutical compounds
US6207142B1 (en) 1997-04-14 2001-03-27 Janssen Pharmaceutica N.V. Compositions containing an antifungal and a cationic agent
WO1999009997A1 (en) * 1997-08-26 1999-03-04 Board Of Regents, The University Of Texas System Edta and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections
US6197305B1 (en) 1998-01-05 2001-03-06 Farmo-Nat Ltd. Anti-fungal compositions with prolonged activity
KR100269323B1 (ko) 1998-01-16 2000-10-16 윤종용 반도체장치의백금막식각방법
US5972358A (en) 1998-01-20 1999-10-26 Ethicon, Inc. Low tack lotion, gels and creams
US20020022660A1 (en) 1998-01-20 2002-02-21 Hanuman B. Jampani Deep penetrating antimicrobial compositions
US5997893A (en) 1998-01-20 1999-12-07 Ethicon, Inc. Alcohol based anti-microbial compositions with cosmetic appearance
US6022551A (en) 1998-01-20 2000-02-08 Ethicon, Inc. Antimicrobial composition
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
AU755531B2 (en) 1998-04-03 2002-12-12 Colgate-Palmolive Company, The Improved low residue cosmetic composition
US6306375B1 (en) 1998-05-01 2001-10-23 The Procter & Gamble Company Long wear nail polish having defined surface properties
US20030007939A1 (en) 1998-07-31 2003-01-09 Howard Murad Pharmaceutical compositions and methods for managing dermatological conditions
US6264927B1 (en) 1998-08-27 2001-07-24 Elmer P. Monahan Topical solution and method for the treatment of nail fungus
US6740326B1 (en) 1998-09-10 2004-05-25 Bioequal Ag Topical nail care compositions
US7026308B1 (en) 1999-06-25 2006-04-11 The Procter & Gamble Company Topical anti-microbial compositions
PT1205559E (pt) 1999-07-28 2009-08-04 Kaken Pharma Co Ltd Método para detectar microrganismos patogénicos e agentes antimicrobianos, método para avaliar o efeito medicamentoso de agentes antimicrobianos e agentes antimicrobianos
MXPA02001144A (es) 1999-07-30 2002-08-20 Procter & Gamble Metodo para tratar y evitar trastornos de dedo.
JP4780429B2 (ja) * 2000-04-07 2011-09-28 大正製薬株式会社 ミノキシジル含有製剤
US6433073B1 (en) 2000-07-27 2002-08-13 3M Innovative Properties Company Polyurethane dispersion in alcohol-water system
US6676953B2 (en) 2001-01-26 2004-01-13 Don L. Hexamer Antifungal composition and method for human nails
US6585963B1 (en) 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
US20030039621A1 (en) 2001-04-10 2003-02-27 L'oreal Two-coat make-up product, its use and a kit containing the make-up product
US6664292B2 (en) 2001-06-04 2003-12-16 Mark H. Bogart Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor
US6821508B2 (en) 2001-06-27 2004-11-23 Rutgers, The State University Composition and method for topical nail treatment
WO2003013447A2 (en) 2001-08-07 2003-02-20 Dow Corning Corporation Hair and skin care compositions containing siloxane-based polyamide copolymers
US7043791B2 (en) 2001-10-16 2006-05-16 Aubex Corporation Applicator
US6846837B2 (en) 2002-06-21 2005-01-25 Howard I. Maibach Topical administration of basic antifungal compositions to treat fungal infections of the nails
JP2004083439A (ja) 2002-08-23 2004-03-18 Ss Pharmaceut Co Ltd 爪用抗真菌外用剤
EP1545619B1 (en) 2002-09-05 2008-01-23 Galderma S.A. Solution for ungual application
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US20050142094A1 (en) 2003-03-12 2005-06-30 Manoj Kumar Use of repeat sequence protein polymers in personal care compositions
US20040180025A1 (en) 2003-03-12 2004-09-16 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
US7462362B2 (en) 2003-03-21 2008-12-09 Nexmed Holdings, Inc. Antifungal nail coat and method of use
FR2856301B1 (fr) 2003-06-23 2007-08-03 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
GB2407496A (en) 2003-10-27 2005-05-04 Dow Corning Method for forming a polysiloxane film on a biological surface
JP2007511578A (ja) 2003-11-21 2007-05-10 ガルデルマ・リサーチ・アンド・デヴェロップメント・エス・エヌ・セ ビタミンｄの投与のためのスプレー可能な組成物
FR2862540B1 (fr) 2003-11-21 2007-03-30 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
WO2005065668A2 (en) 2003-12-29 2005-07-21 Qlt Usa, Inc. Topical compositions comprising halo-deoxyadenosines for treatment of skin disorders
US7622844B1 (en) 2003-12-30 2009-11-24 Hipercon, Llc Metal fiber brush interface conditioning
US20050176650A1 (en) 2004-02-09 2005-08-11 Xanodyne Pharmacal, Inc. Stable parenteral formulation of levomepromazine and a method for stabilizing said formulation
FR2871697B1 (fr) 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
US20060008538A1 (en) 2004-07-07 2006-01-12 Wu Jeffrey M Methods of treating the skin
US20070082039A1 (en) 2004-10-18 2007-04-12 Jones Gerald S Jr Synthesis of fatty alcohol esters of alpha-hydroxy carboxylic acids, the use of the same as percutaneous permeation enhancers, and topical gels for the transdermal delivery of steroids
US20060110415A1 (en) 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US20060165747A1 (en) 2005-01-24 2006-07-27 David Rolf Antifungal composition, method and kit for topically treating onychomycosis
US7767657B2 (en) 2005-02-16 2010-08-03 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
SI3424932T1 (sl) 2005-02-16 2021-08-31 Anacor Pharmaceuticals, Inc. Boronoftalidi za terapevtsko uporabo
US20060280706A1 (en) 2005-05-25 2006-12-14 L'oreal Rinse-off cosmetic composition containing interference particles
US20070071705A1 (en) 2005-09-29 2007-03-29 De Oliveira Monica A M Topical anti-microbial compositions
EP1959929A4 (en) 2005-12-14 2012-08-15 Zars Pharma Inc COMPOSITIONS AND METHODS FOR TREATING DERMATOLOGICAL SUFFERING
US20070142478A1 (en) 2005-12-21 2007-06-21 Erning Xia Combination antimicrobial composition and method of use
EP1998788A4 (en) 2006-03-01 2011-08-03 Ruey J Yu COMPOSITIONS AND METHODS FOR THE TOPIC TREATMENT OF DERMATOLOGICAL DISORDERS RESPONSIBLE FOR TAR
US20070207107A1 (en) 2006-03-03 2007-09-06 Gareth Winckle Silicone based emulsions for topical drug delivery
JP5184341B2 (ja) 2006-03-08 2013-04-17 日本農薬株式会社 外用の医薬組成物
EP1998742A2 (en) 2006-03-08 2008-12-10 Nuviance, INC. Transdermal drug delivery compositions and topical compositions for application on the skin
US7950865B2 (en) 2006-03-21 2011-05-31 L'oreal Packaging and applicator device
DK2010220T3 (da) 2006-04-03 2022-05-23 Ceva Animal Health Pty Ltd Stabiliserede pentosanpolysulfat-(pps)-formuleringer
WO2008001200A2 (en) 2006-06-29 2008-01-03 Antares Pharma Ipl Ag Transdermal composition having enhanced color stability
MXPA06008988A (es) 2006-08-08 2008-02-07 Fernando Ahumada Ayala Preparaciones topicas antiacne que contienen retinoide (tazaroteno o adapaleno), antibiotico (fosfato de clindamicina) y/o queratolitico (peroxido de bonzoilo en microesponjas).
US20080317684A1 (en) 2006-09-06 2008-12-25 Isw Group, Inc. Topical Compositions
CA2673976C (en) 2006-12-28 2015-02-17 Kaken Pharmaceutical Co., Ltd. Gel composition for treating mycosis
WO2008124131A1 (en) * 2007-04-05 2008-10-16 The John Hopkins University Antifungal agents as neuroprotectants
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
JP2009263346A (ja) 2008-03-31 2009-11-12 Kose Corp カイネチンを含有する乳化型化粧料
BRPI0924302A2 (pt) * 2009-02-05 2019-09-24 Targeted Delivery Tech Limited métodos de reduzir a proliferação e a viabilidade de agentes microbianos
EP2395839B1 (en) 2009-02-13 2014-05-07 Topica Pharmaceuticals, Inc Anti-fungal formulation
FR2942716B1 (fr) 2009-03-06 2011-04-15 Galderma Res & Dev Methode de solubilisation d'agent antifongique et compositions a haute concentration en agent antifongique applicables sur l'ongle
US20120183531A1 (en) 2009-07-14 2012-07-19 Biogen Idee Ma Inc Methods for Inhibiting Yellow Color Formation in a Composition
WO2011045765A1 (en) * 2009-10-14 2011-04-21 Scuola Internazionale Superiore Di Studi Avanzati TEMPORALLY PATTERNED OVEREXPRESSION OF Foxg1 AND Emx2 TRANSCRIPTION FACTOR GENES IN NEURAL PRECURSORS FOR BRAIN TISSUE REPAIR
WO2011064558A2 (en) * 2009-11-30 2011-06-03 Cipla Limited Pharmaceutical composition
FR2954164B1 (fr) 2009-12-18 2012-03-16 Galderma Pharma Sa Composition antifongique destinee a etre appliquee sur l'ongle perfore
CN102958520A (zh) * 2010-05-20 2013-03-06 郑忠铉 具抗细菌及抗真菌效果的皮肤外用组合物
KR101834024B1 (ko) 2010-06-29 2018-03-02 머크 샤프 앤드 돔 코포레이션 치환된 베타―시클로덱스트린에 의해 안정화된 포사코나졸 정맥내 용액 제제
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
CA2808230C (en) * 2010-08-31 2017-02-28 Kaken Pharmaceutical Co., Ltd. Process for producing 1-triazole-2-butanol derivatives
JP6005344B2 (ja) 2011-07-05 2016-10-12 科研製薬株式会社 爪白癬薬用塗布具
US9493582B2 (en) 2012-02-28 2016-11-15 Cydex Pharmaceuticals, Inc. Alkylated cyclodextrin compositions and processes for preparing and using the same
MY179756A (en) 2013-10-03 2020-11-12 Dow Pharmaceutical Sciences Stabilized efinaconazole formulations
EP3071295A4 (en) 2013-11-22 2017-05-31 Dow Pharmaceutical Sciences, Inc. Anti-infective methods, compositions, and devices

Similar Documents

Publication Publication Date Title
JP2016532722A5 (enExample)
JP2019108388A5 (enExample)
HK1247822A1 (zh) 用於活性剂口服给药的制剂
WO2017022962A8 (ko) Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
EP4241850A3 (en) Mdm2 inhibitors and combinations thereof
WO2017042607A3 (en) Compositions comprising meloxicam-cyclodextrin inclusion complexes and methods of treating acute pain
MX2020001403A (es) Nuevos derivados de quinolina.
CN108026053A8 (zh) 作为mIDH1抑制剂的稠合的咪唑类化合物
AR094374A1 (es) Composiciones y métodos para el tratamiento de trastornos metabólicos
HK1251481A1 (zh) 使用白介素-17(il-17)拮抗剂治疗放射学阴性中轴型脊柱关节炎的方法
MX2020010300A (es) Sales monoacidas de 6-aminoisoquinolinas y usos de las mismas.
MY163235A (en) Pharmaceutical preparation containing pyridylaminoacetic acid compound
RU2017116740A (ru) Комбинации для лечения рассеянного склероза
JP2016503058A5 (enExample)
PH12019500618A1 (en) Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease
WO2016168553A8 (en) Deuterated obeticholic acid
EA201791138A1 (ru) Фармацевтическая композиция, ее приготовление и применения
WO2015150449A3 (en) Amido-substituted azole compounds as inhibitors of tnks1 and/or tnks2
WO2014052780A3 (en) Compositions and methods of use of an inappetance-controlling compound
EA201792264A1 (ru) Способы лечения воспалительных заболеваний
JOP20190156B1 (ar) أميدات عطرية لحمض الكربوكسيليك بصفتها مضادات لمستقبلة البراديكينين b1
HK1203394A1 (en) Ghrelin receptor agonists for the treatment of achlorhydria
JP2014530204A5 (enExample)
HK1243704A1 (zh) 用於在未接触疟疾的受试者中预防疟疾的他非诺喹的新方案
WO2019004788A3 (ko) 브라우쏘칼콘 a를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 약학 조성물